Previously published associations between circulating endostatin levels and survival in PAH have been inconsistent, losing significance with adjustment for established disease severity markers, including 6MWD, New York Heart Association Functional Class (NYHA FC) and NTproBNP [14]. Here, NPPB is linked to pulmonary arterial hypertension.